New drug trial offers hope for Tough-to-Treat pancreatic cancer
NCT ID NCT07301229
Summary
This study is testing an experimental drug called HLX43 in people with advanced pancreatic cancer that has continued to grow despite standard treatments. About 100 participants will receive the drug through an IV to see if it can shrink tumors and is safe to use. The main goals are to find the right dose and measure how well the cancer responds.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.